The source of dietary fatty acids alters the activity of secretory sphingomyelinase in the rat

European Journal of Lipid Science and Technology

Volumn 109, Issue 10, 2007, Pages 1003-1009

  Drachmann, Tue ^a   Mathiessen, Jacob H ^a   Pedersen, Maiken H ^a   Hellgren, Lars I ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Butter; Ceramide; N 3 PUFA; Sphingolipids; Sphingomyelin

Indexed keywords

RATTUS;

EID: 35548958684     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.200600240     Document Type: Conference Paper

References (37)

1. E. Warensjo, J. H. Jansson, L. Berglund, K. Boman, B. Ahren, L. Weinehall, B. Lindahl, G. Hallmans, B. Vessby:Estimated intake of milk fat is negatively associated with cardiovascular risk factors and does not increase the risk of a first acute myocardial infarction. A prospective case-control study. Br J Nutr. 2004, 91, 635-642.
2. A. S. Biong, M. B. Veierod, J. Ringstad, D. S. Thelle, J. I. Pedersen:Intake of milk fat, reflected in adipose tissue fatty acids and risk of myocardial infarction: A case-control study. Eur J Clin Nutr. 2006, 60, 236-244.
3. T. Levade, N. Auge, R. J. Veldman, O. Cuvillier, A. Negre-Salvayre, R. Salvayre: Sphingolipid mediators in cardiovascular cell biology and pathology. Circulation Res. 2001, 89, 957-968.
4. N. Augé, A. Nègre-Salvayre, R. Salvayre, T. Levade: Sphingomyelin metabolites in vascular cell signaling and atherogenesis. Prog Lipid Res. 2000, 39, 207-229.
5. K. Öörni, P. Posio, M. Ala-Korpela, M. Jauhiainen, P. T. Kovanen:Sphingomyelinase induces aggregation and fusion of small very low-density lipoprotein and intermediate-density lipoprotein particles and increases their retention to human arterial proteoglycans .Arterioscler Thromb Vasc Biol. 2005, 25, 1678-1683.
6. S. Marathe, Y. Choi, A. R. Leventhal, I. Tabas: Sphingomyelinase converts lipoproteins from apolipoprotein E knockout mice into potent inducers of macrophage foam cell formation. Arterioscler Thromb Vasc Biol. 2000, 20, 2607-2613.
7. S.-y. Morita, M. Kawabe, A. Sakurai, K. Okuhira, A. Vertut-Doi, M. Nakano, T. Handa:Ceramide in lipid particles enhances heparan sulfate proteoglycan and low density lipoprotein receptor-related protein-mediated uptake by macrophages. J Biol Chem. 2004, 279, 24355-24361.
8. T. S. Park, R. L. Panek, S. B. Mueller, J. C. Hanselman, W. S. Rosebury, A. W. Robertson, E. K. Kindt, R. Homan, S. K. Karathanasis, M. D. Rekhter: Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice. Circulation. 2004, 110, 3465-3471.
9. A. Loidl, R. Claus, E. Ingolic, H.-P. Deigner, A. Hermetter: Role of ceramide in activation of stress-associated MAP kinases by minimally modified LDL in vascular smooth muscle cells. Biochim Biophys Acta. 2004, 1690, 150-158.
10. B. Boyanovsky, A. Karakashian, K. King, N. Giltiay, M. Nikolova-Karakashian:Uptake and metabolism of low density lipoproteins with elevated ceramide content by human microvascular endothelial cells: Implications for the regulation of apoptosis. J Biol Chem. 2003, 278, 26992-26999.
11. S. Lightle, R. Tosheva, A. Lee, J. Queen-Baker, B. Boyanovsky, S. Shedlofsky, M. Nikolova-Karakashian:Elevation of ceramide in serum lipoproteins during acute phase response in humans and mice: Role of serine-palmitoyl transferase. Arch Biochem Biophys. 2003, 419, 120-128.
12. M. L. Wong, B. Xie, N. Beatini, P. Phu, S. Marathe, A. Johns, P. W. Gold, E. Hirsch, K. J. Williams, J. Licinio, I. Tabas: Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: A possible link between inflammatory cytokines and atherogenesis. Proc Natl Acad Sci USA. 2000, 97, 8681-8686.
13. S. Marathe, S. L. Schissel, M. J. Yellin, N. Beatini, R. Mintzer, K. J. Williams, I. Tabas:Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling. J Biol Chem. 1998, 273, 4081-4088.
14. 2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J Biol Chem. 1996, 271, 18431-18436.
15. S. Marathe, G. Kuriakose, K. J. Williams, I. Tabas: Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix. Arterioscler Thromb Vase Biol. 1999, 19, 2648-2658.
16. E. Aaes-Jørgensen, G. Hølmer: Essential fatty acid-deficient rats. I. Growth and testes development. Lipids. 1969, 4, 501-506.
17. J. Folch, M. Lees, G. H. S. Stanley: A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem. 1957, 226, 497-509.
18. S. W. Christopherson, R. L. Glass:Preparation of milk fat methyl esters by alcoholysis in an essentially nonalcoholic solution. J Dairy Sci. 1969, 52, 1289-1290.
19. J. R. Hamilton, S. Hamilton, P. A. Sewell: Extraction of lipids and derivative formation. Lipid Analysis - A Practical Approach. Eds. J. R. Hamilton, S. Hamilton, IRL Press, Oxford (UK) 1992, pp 13-64.
20. J. Bodennec, G. Brichon, G. Zwingelstein, J. Portoukalian:Purification of sphingolipid classes by solid-phase extraction with aminopropyl and weak cation exchanger cartridges. Meth Enzymol. 2000, 312, 101-114.
21. R. Bose, P. Chen, A. Loconti, C. Grullich, J. M. Abrams, R. N. Kolesnick:Ceramide generation by the Reaper protein is not blocked by the caspase inhibitor, p35. J Biol Chem. 1998, 273, 28852-28859.
22. A. H. Merrill Jr., E. Wang, R. E. Mullins, W. C. L. Jamison, S. Nimkar, D. C. Liotta:Quantitation of free sphingosine in liver by high-performance liquid chromatography. Anal Biochem. 1988, 171, 373-381.
23. H. Müller, L. I. Hellgren, E. Olsen, A. Skrede:Lipids rich in phosphatidylethanolamine from natural gas-utilising bacteria reduce plasma cholesterol and classes of phospholipids: A comparison with soybean oil. Lipids. 2004, 39, 833-841.
24. S. L. Schissel, X. Jiang, J. Tweedie-Hardman, T. Jeong, E. H. Camejo, J. Najib, J. H. Rapp, K. J. Williams, I. Tabas: Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J Biol Chem. 1998, 273, 2738-2746.
25. M. Naghavi, R. John, S. Naguib, M. S. Siadaty, R. Grasu, K. C. Kurian, W. B. van Winkle, B. Soller, S. Litovsky, M. Madjid: pH heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque. Atherosclerosis. 2002, 164, 27-35.
26. I. A. Silver, R. J. Murrills, D. J. Etherington: Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res. 1988, 175, 266-276.
27. J. J. Liu, A. Nilsson, R. D. Duan: In vitro effects of fat, FA, and cholesterol on sphingomyelin hydrolysis induced by rat intestinal alkaline sphingomyelinase. Lipids. 2002, 37, 469-474.
28. S. Jayadev, C. M. Linardic, Y. A. Hannun:Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor alpha. J Biol Chem. 1994, 269, 5757-5763.
29. B. S. Robinson, C. S. Hii, A. Poulos, A. Ferrante:Activation of neutral sphingomyelinase in human neutrophils by polyunsaturated fatty acids. Immunology. 1997, 91, 274-280.
30. M. Wu, K. A. Harvey, N. Ruzmetov, Z. R. Welch, L. Sech, K. Jackson, W. Stillwell, G. P. Zaloga, R. A. Siddiqui:Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway. Int J Cancer. 2005, 117, 340-348.
31. T. S. Worgall, R. A. Johnson, T. Seo, H. Gierens, R. J. Deckelbaum:Unsaturated fatty acid-mediated decreases in sterol regulatory element-mediated gene transcription are linked to cellular sphingolipid metabolism. J Biol Chem. 2002, 277, 3878-3885.
32. A. P. Simopoulos: Essential fatty acids in health and chronic disease. Am J Clin Nutr. 1999, 70, 560-569.
33. L. G. Cleland, R. A. Gibson, J. Pedler, M. J. James:Paradoxical effect of n-3-containing vegetable oils on long-chain n-3 fatty acids in rat heart. Lipids. 2005, 40, 995-998.
34. H. P. Cho, M. T. Nakamura, S. D. Clarke:Cloning, expression, and nutritional regulation of the mammalian delta-6 desaturase. J Biol Chem. 1999, 274, 471-477.
35. P. C. Calder:n-3 Polyunsaturated fatty acids and cytokine production in health and disease. Ann NutrMetab. 1997, 41, 203-234.
36. A. P. Simopoulos:Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002, 21, 495-505.
37. C. H. Lai, J. D. Yin, D. F. Li, L D. Zhao, S. Y. Qiao, J. J. Xing:Conjugated linoleic acid attenuates the production and gene expression of proinflammatory cytokines in weaned pigs challenged with lipopolysaccharide. J Nutr. 2005, 135, 239-244.